FDA Approves Omalizumab for Multiple Food Allergy

Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.

Related Keywords

United States , ,Genentech ,Division Of Pulmonology ,Drug Administration ,Kelly Stone ,Critical Care ,Drug Evaluation ,Food Allergy ,Food Hypersensitivity ,Otolaryngology ,Nt Specialty ,Ead And Neck Surgery Ent Speciality ,Allergy ,Anaphylaxis ,Allergy Induced Asthma ,Allergic Asthma ,Asthma ,Sthmatic ,Bige ,Immunoglobulin E ,Allergens ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Fever ,Pyrexia ,Ebrile Response ,Riga ,Immunoglobulin A ,Pain Management ,Arthralgia ,Ainful Joint ,Joint Pain ,Adverse Effects ,